论文部分内容阅读
本刊讯近日,解放军302医院临床检验医学中心科研人员开发出一种针对丙型肝炎患者的新型基因检测技术。该技术对患者本身的白介素28B基因进行多态性分析,在国内率先将多色荧光探针技术(PCR)运用于丙肝患者临床抗病毒疗效的预测和评估中。这为陕速检测丙肝患者对某种抗病毒药物是否有效提供了重要依据,从而更有效地指导临床医务人员准确选择用药,提升治疗效果。由于患者身体基因型的不同而导致抗病毒用药使用疗效的差异,
Recently, the People’s Liberation Army 302 Hospital Clinical Laboratory Medical Science and Technology researchers developed a new type of genetic testing for patients with hepatitis C technology. The technology of the patient’s own interleukin 28B gene polymorphism analysis in the first multi-color fluorescent probe technology (PCR) used in the clinical evaluation of anti-HCV efficacy in patients with hepatitis C in the assessment. This provides an important basis for the detection of hepatitis C patients in Shaanxi Province for the effectiveness of some antiviral drugs, so as to guide clinical medical staff to select the medication accurately and improve the treatment effect. Due to the differences in the patient’s body genotypes leading to differences in the efficacy of antiviral drugs,